Pericardial effusion primary prevention

Revision as of 21:29, 26 November 2019 by Roukoz Abou Karam (talk | contribs) (Created page with "__NOTOC__ {{Pericardial effusion}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no available v...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Pericardial effusion Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pericardial effusion from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Cardiac Catheterization

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Pericardial Window

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Pericardial effusion primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pericardial effusion primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pericardial effusion primary prevention

CDC on Pericardial effusion primary prevention

Pericardial effusion primary prevention in the news

Blogs on Pericardial effusion primary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pericardial effusion primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include:

  • [Measure1]
  • [Measure2]
  • [Measure3]

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

References



Linked-in.jpg